CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 37 filers reported holding CATALYST BIOSCIENCES INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $16,512 | +3.2% | 31,303 | +80.1% | 0.00% | – |
| Q4 2021 | $16,000 | -72.4% | 17,379 | +50.7% | 0.00% | – |
| Q1 2021 | $58,000 | -63.3% | 11,529 | -68.7% | 0.00% | – |
| Q3 2020 | $158,000 | +53.4% | 36,780 | +109.2% | 0.00% | – |
| Q2 2020 | $103,000 | -3.7% | 17,583 | +21.0% | 0.00% | – |
| Q2 2019 | $107,000 | – | 14,534 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 471,448 | $5,502,000 | 3.04% |
| ACUTA CAPITAL PARTNERS, LLC | 830,000 | $9,686,000 | 1.72% |
| NEXTHERA CAPITAL LP | 786,865 | $9,183,000 | 1.42% |
| Ghost Tree Capital, LLC | 355,000 | $4,143,000 | 1.22% |
| Point72 Europe (London) LLP | 83,500 | $974,000 | 0.52% |
| Virtus ETF Advisers LLC | 31,061 | $362,000 | 0.32% |
| Eventide Asset Management | 246,000 | $2,871,000 | 0.12% |
| Kalos Management, Inc. | 8,500 | $244,000 | 0.11% |
| MARSHALL WACE, LLP | 550,352 | $6,423,000 | 0.10% |
| GSA CAPITAL PARTNERS LLP | 157,145 | $1,834,000 | 0.09% |